Pnc Financial Services Group, Inc. Dia Medica Therapeutics Inc. Transaction History
Pnc Financial Services Group, Inc.
- $162 Billion
- Q3 2025
A detailed history of Pnc Financial Services Group, Inc. transactions in Dia Medica Therapeutics Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 450 shares of DMAC stock, worth $2,682. This represents 0.0% of its overall portfolio holdings.
Number of Shares
450Holding current value
$2,682% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding DMAC
# of Institutions
81Shares Held
8.02MCall Options Held
19.6KPut Options Held
16.5K-
Israel Englander Millennium Management LLC | New York, Ny1.19MShares$7.08 Million0.0% of portfolio
-
Paragon Associates & Paragon Associates Ii Joint Venture Dallas, TX875KShares$5.22 Million11.8% of portfolio
-
Geode Capital Management, LLC Boston, MA712KShares$4.24 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA665KShares$3.96 Million0.0% of portfolio
-
Morgan Stanley New York, NY580KShares$3.45 Million0.0% of portfolio
About DiaMedica Therapeutics Inc.
- Ticker DMAC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,443,100
- Market Cap $158M
- Description
- DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, develops treatments for neurological and kidney diseases. The company's lead drug candidate is DM199, a recombinant human tissue kallikrein-1 protein, which is in Phase 2 REDUX trial for the treatment of patients with moderate or severe chronic kidney disease caused by Type...